A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]

BACKGROUND: Etoricoxib is a highly selective COX-2 inhibitor which was evaluated for the treatment of rheumatoid arthritis (RA). METHODS: Double-blind, randomized, placebo and active comparator-controlled, 12-week study conducted at 67 sites in 28 countries. Eligible patients were chronic NSAID user...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Collantes, Eduardo, Curtis, Sean P, Lee, Ka Wing, Casas, Noemi, McCarthy, Timothy, Melian, Agustin, Zhao, Peng L, Rodgers, Diana B, McCormick, Calogera L, Lee, Michael, Lines, Christopher R, Gertz, Barry J
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2002
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC115849/
https://ncbi.nlm.nih.gov/pubmed/12033987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2296-3-10
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares